Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/26/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. NDAQ
9. TSCO
10. BE

Go back to Intellia Therapeutics Announces First Quarter 2019 Financial Results and Company Update

Intellia Therapeutics (NTLA) Reports Q1 Loss of $0.49/Share

May 2, 2019 7:43 AM EDT

Intellia Therapeutics (NASDAQ: NTLA) reported Q1 EPS of ($0.49), versus ($0.51) reported last year. Revenue for the quarter came in at $10.43 million, versus $7.47 million reported last year.

For earnings history and earnings-related data on Intellia Therapeutics (NTLA) click here.

... More